Madhu Mahankali, PhD (she/her/hers)

Principal Scientist
Spirovant Sciences, Inc

Poster(s):

• (621) Administration of SP-101 and Doxorubicin Results in Robust and Durable hCFTRΔR Transgene Expression in the Airways of Ferrets and Corrects Human CF Airway Epithelia In Vitro
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (643) Delivery of gp64-pseudotyped lentivirus carrying codon-optimized CFTR provides improved functional restoration in human CF airway epithelial cultures
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (672) SP-101 activity increases in a dose dependent manner to both vector and doxorubicin dose
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET